Diabetes and its complications activate NLRP3 inflammasome through hyperglycemia, hypercholesterolemia, and hyperuricemia, resulting in a rise of IL-1β and IL-18 levels and inducing inflammatory response (Schroder et al., 2010). The gene discussed is NLRP3; the disease is diabetes mellitus.